180 related articles for article (PubMed ID: 28440616)
1. Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay.
Iwatani-Yoshihara M; Ito M; Ishibashi Y; Oki H; Tanaka T; Morishita D; Ito T; Kimura H; Imaeda Y; Aparicio S; Nakanishi A; Kawamoto T
ACS Chem Biol; 2017 Jul; 12(7):1760-1768. PubMed ID: 28440616
[TBL] [Abstract][Full Text] [Related]
2. Discovery of selective ATP-competitive eIF4A3 inhibitors.
Ito M; Iwatani M; Kamada Y; Sogabe S; Nakao S; Tanaka T; Kawamoto T; Aparicio S; Nakanishi A; Imaeda Y
Bioorg Med Chem; 2017 Apr; 25(7):2200-2209. PubMed ID: 28283335
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.
Ito M; Tanaka T; Cary DR; Iwatani-Yoshihara M; Kamada Y; Kawamoto T; Aparicio S; Nakanishi A; Imaeda Y
J Med Chem; 2017 Apr; 60(8):3335-3351. PubMed ID: 28358513
[TBL] [Abstract][Full Text] [Related]
4. Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays.
Nakao S; Nogami M; Iwatani M; Imaeda T; Ito M; Tanaka T; Tawada M; Endo S; Cary DR; Ohori M; Imaeda Y; Kawamoto T; Aparicio S; Nakanishi A; Araki S
Biochem Biophys Res Commun; 2020 Mar; 523(3):795-801. PubMed ID: 31954521
[TBL] [Abstract][Full Text] [Related]
5. Exploring the targeting spectrum of rocaglates among eIF4A homologs.
Naineni SK; Cencic R; Robert F; Brown LE; Haque M; Scott-Talib J; Sénéchal P; Schmeing TM; Porco JA; Pelletier J
RNA; 2023 Jun; 29(6):826-835. PubMed ID: 36882295
[TBL] [Abstract][Full Text] [Related]
6. eIF4A3 is a novel component of the exon junction complex.
Chan CC; Dostie J; Diem MD; Feng W; Mann M; Rappsilber J; Dreyfuss G
RNA; 2004 Feb; 10(2):200-9. PubMed ID: 14730019
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Based Screen Links an Inhibitor of Nonsense-Mediated Decay to eIF4A3 Target Engagement.
Cencic R; Naineni SK; Pugsley L; Senéchal P; Sahni A; Pelletier J
ACS Chem Biol; 2020 Jun; 15(6):1621-1629. PubMed ID: 32401488
[TBL] [Abstract][Full Text] [Related]
8. eIF4A3 Phosphorylation by CDKs Affects NMD during the Cell Cycle.
Ryu I; Won YS; Ha H; Kim E; Park Y; Kim MK; Kwon DH; Choe J; Song HK; Jung H; Kim YK
Cell Rep; 2019 Feb; 26(8):2126-2139.e9. PubMed ID: 30784594
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation.
Mazloomian A; Araki S; Ohori M; El-Naggar AM; Yap D; Bashashati A; Nakao S; Sorensen PH; Nakanishi A; Shah S; Aparicio S
Commun Biol; 2019; 2():165. PubMed ID: 31069274
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of human eIF4AIII identifies regions necessary for exon junction complex formation and nonsense-mediated mRNA decay.
Shibuya T; Tange TØ; Stroupe ME; Moore MJ
RNA; 2006 Mar; 12(3):360-74. PubMed ID: 16495234
[TBL] [Abstract][Full Text] [Related]
11. Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of exon junction complex components.
Zhang Z; Krainer AR
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11574-9. PubMed ID: 17606899
[TBL] [Abstract][Full Text] [Related]
12. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E
Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063
[TBL] [Abstract][Full Text] [Related]
13. Effect of eukaryotic translation initiation factor 4A3 in malignant tumors.
Zhu Y; Ren C; Yang L
Oncol Lett; 2021 May; 21(5):358. PubMed ID: 33747215
[TBL] [Abstract][Full Text] [Related]
14. Eif4a3 is required for accurate splicing of the Xenopus laevis ryanodine receptor pre-mRNA.
Haremaki T; Weinstein DC
Dev Biol; 2012 Dec; 372(1):103-10. PubMed ID: 22944195
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract][Full Text] [Related]
16. The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression.
Meznad K; Paget-Bailly P; Jacquin E; Peigney A; Aubin F; Guittaut M; Mougin C; Prétet JL; Baguet A
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33760064
[TBL] [Abstract][Full Text] [Related]
17. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output.
Kanellis DC; Espinoza JA; Zisi A; Sakkas E; Bartkova J; Katsori AM; Boström J; Dyrskjøt L; Broholm H; Altun M; Elsässer SJ; Lindström MS; Bartek J
Sci Adv; 2021 Aug; 7(32):. PubMed ID: 34348895
[TBL] [Abstract][Full Text] [Related]
18. Selective pharmacological targeting of a DEAD box RNA helicase.
Lindqvist L; Oberer M; Reibarkh M; Cencic R; Bordeleau ME; Vogt E; Marintchev A; Tanaka J; Fagotto F; Altmann M; Wagner G; Pelletier J
PLoS One; 2008 Feb; 3(2):e1583. PubMed ID: 18270573
[TBL] [Abstract][Full Text] [Related]
19. EIF4A3: a gatekeeper of autophagy.
Sakellariou D; Frankel LB
Autophagy; 2021 Dec; 17(12):4504-4505. PubMed ID: 34643458
[TBL] [Abstract][Full Text] [Related]
20. eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay.
Shibuya T; Tange TØ; Sonenberg N; Moore MJ
Nat Struct Mol Biol; 2004 Apr; 11(4):346-51. PubMed ID: 15034551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
